Every stage of drug development has its own complex challenges. The rise of precision medicine in oncology has made it imperative for drug companies to have detailed, documented strategies for advancing their drug.

During this on-demand webinar, our own industry expert, Corinne Ramos, PhD, discusses different methods to help assist with your process. This presentation reviews:

1. Today’s era of precision medicine and the impact it has on how you validate your compound
2. How you can utilize mass spectrometry imaging to further understand efficacy
3. Advancing biomarker into drug development – how can you create strategies to do so?
4. Patient selection in clinical trials